Rezai Jahromi Behnam, Valori Miko, Tulamo Riikka, Jauhiainen Suvi, Ilmonen Henna, Kantonen Jonas, Kaikkonen-Määttä Minna, Laakso Aki, Ylä-Hertuala Seppo, Jääskeläinen Juha E, Tienari Pentti J, Niemelä Mika
Department of Neurosurgey, Neurocenter, Helsinki University Hospital, Helsinki, Finland.
Neurosurgery Research Group, Biomedicum, University of Helsinki, Helsinki, Finland.
Eur J Hum Genet. 2025 Aug;33(8):1076-1079. doi: 10.1038/s41431-024-01765-x. Epub 2024 Dec 12.
Intracranial aneurysms (IAs) are a major cause of subarachnoidal hemorrhage (SAH) which can have a significant morbidity and mortality. The processes underlying the aneurysm development remains unclear. We performed whole exome sequencing of DNA derived from 20 saccular cerebral aneurysms of 20 patients, followed by somatic variant calling. Eleven (55%) of the 20 patients had detectable nonsynonymous somatic mutations and in total, 48 mutations were detected in the aneurysm samples. The mutations were highly enriched in cancer-related genes and 77% were predictably deleterious. A p.Tyr562Asp somatic mutation was detected in the PDGFRB gene; somatic mutations at the same codon have been reported in fusiform cerebral aneurysms. These results widen the concept on the role of somatic mutations in cerebral aneurysms, indicating their possible role in the more common saccular aneurysm, similarly to the rarer fusiform aneurysm.
颅内动脉瘤(IAs)是蛛网膜下腔出血(SAH)的主要原因,SAH可导致显著的发病率和死亡率。动脉瘤形成的潜在机制尚不清楚。我们对20例患者的20个囊状脑动脉瘤的DNA进行了全外显子组测序,随后进行体细胞变异检测。20例患者中有11例(55%)检测到可检测的非同义体细胞突变,在动脉瘤样本中总共检测到48个突变。这些突变在癌症相关基因中高度富集,77%的突变可预测为有害突变。在PDGFRB基因中检测到p.Tyr562Asp体细胞突变;在梭形脑动脉瘤中也报道了相同密码子的体细胞突变。这些结果拓宽了体细胞突变在脑动脉瘤中作用的概念,表明它们在更常见的囊状动脉瘤中可能发挥的作用,类似于罕见的梭形动脉瘤。